{
  "figure_1": "Research design.",
  "figure_2": "Expression of SLC7A3 in cancer. (A) SLC7A3 expression in different types of cancer was investigated using the TIMER database. (B) Decreased expression of SLC7A3 in breast cancer compared to normal tissues in the GEPIA database. (C) SLC7A3 expression in breast cancer was examined by using the UALCAN database. (D) Immunohistochemical staining of SLC7A3 was performed in ER-positive breast cancer and normal breast tissues. Representative images are shown. Scare bars, 50Î¼m. (E) Analysis of SLC7A3 expression in ER-positive breast cancer and adjacent normal tissues based on IHC score. (F) SLC7A3 expression in breast cancer and normal tissues. *p<0.05, **p<0.01, ***p<0.0001.",
  "figure_3": "Box plots evaluating SLC7A3 expression among different groups of patients based on clinical parameters using the UALCAN database. Analysis is shown for cancer stages (A), nodal metastasis status (B), TP53 mutation status (C), patient race (D), breast cancer subclasses (E), TNBC type (F), pathological subtypes (G), and menopause status (H). Abbreviations: BRCA: breast cancer; N0: no regional lymph node metastasis; N1: metastases in 1 to 3 axillary lymph nodes; N2: metastases in 4 to 9 axillary lymph nodes; N3: metastases in 10 or more axillary lymph nodes. TNBC-BL1: TNBC basal-like 1; TNBC-BL2: TNBC basal-like 2; TNBC-IM: TNBC immunomodulatory; TNBC-M: TNBC mesenchymal; TNBC-MSL: TNBC mesenchymal stem-like; TNBC-LAR: TNBC luminal androgen receptor; TNBC-UNS: TNBC unspecified. IDC: infiltrating ductal carcinoma; ILC: infiltrating lobular carcinoma; Mixed: mixed histology; Mucinous: mucinous carcinoma; Medullary: medullary carcinoma; Metaplastic: metaplastic carcinoma; INOS: infiltrating carcinoma not otherwise specified. *p<0.05, **p<0.01, ***p<0.001.",
  "figure_4": "Survival curves evaluating the prognostic value of SLC7A3. (A) OS curves using the Human Protein Atlas. (B) OS curves using the GEPIA database. (C) OS curves using the UALCAN database. (D) DFS curves using the GEPIA database. (E) OS, RFS, DSS and DMFS curves using the PrognoScan database. Abbreviation: BRCA: breast cancer. All dotted lines represent confidence bands.",
  "figure_5": "Survival curve evaluating the prognostic value of SLC7A3. (A) Survival curves using the Kaplan-Meier plotter database are shown for distant metastasis-free survival (DMFS), (B) recurrence-free survival (RFS), and (C) overall survival (OS).",
  "figure_6": "(A and B) The gene-gene interaction network for SLC7A3 was constructed using GeneMANIA. (C) The PPI network of SLC7A3 was generated using STRING. (D and E) Survival curves using the cBioPortal database are shown for RFS and OS.",
  "figure_7": "GO and KEGG enrichment analysis for SLC7A3. (A) Top 20 GO enrichment terms in breast cancer. (B) Top 12 KEGG enrichment pathways in breast cancer. SLC7A3 inhibits the proliferation and invasion of breast cancer cells in vitro."
}